Autoimmune hepatitis in a HIV-HCV co-infected patient: diagnostic ant therapeutic difficulties

被引:15
作者
Cazanave, C.
Rakotondravelo, S.
Morlat, P.
Blanco, P.
Bonnet, F.
Beylot, J.
机构
[1] CHU Bordeaux, Hop St Andre, Serv Med Interne & Malad Infect, F-33075 Bordeaux, France
[2] CHU Bordeaux, Hop Pellegrin, Immunol Lab, F-33076 Bordeaux, France
来源
REVUE DE MEDECINE INTERNE | 2006年 / 27卷 / 05期
关键词
autoimmune hepatitis; HCV; HIV; treatment;
D O I
10.1016/j.revmed.2006.01.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction. - Autoimmune hepatitis (AIH) is a chronic inflammatory hepatic disorder, characterized by hypergammaglobulinemia. and autoantibodies. In some cases, AIH can be associated with another liver disease; such as the hepatitis C-AIH overlap syndrome, which diagnosis and treatment may be delicate. Exegese. - We report a type 1 AIH case in a HIV-HCV co-infected woman. AIH remission and HCV eradication were obtained with prednisone and interferon plus ribavirine. AIH relapse appeared with corticosteroid withdrawal and a new remission was obtained with immunosuppressive treatment associating prednisone and azathioprine, without opportunistic infection. Conclusion. - This case illustrates diagnostic and therapeutic difficulties of hepatitis C-AIH overlap syndromes in an HIV-infected patient. To our knowledge, it is the first AIH case report in a HIV-HCV co-infected patient. (C) 2006 Elsevier SAS. Tons droits reserves.
引用
收藏
页码:414 / 419
页数:6
相关论文
共 24 条
[1]   International Autoimmune Hepatitis Group Report:: review of criteria for diagnosis of autoimmune hepatitis [J].
Alvarez, E ;
Berg, PA ;
Bianchi, FB ;
Bianchi, L ;
Burroughs, AK ;
Cancado, EL ;
Chapman, RW ;
Cooksley, WGE ;
Czaja, AJ ;
Desmet, VJ ;
Donaldson, RT ;
Eddleston, ALWF ;
Fainboim, L ;
Heathcote, J ;
Homberg, JC ;
Hoofnagle, JH ;
Kakumu, S ;
Krawitt, EL ;
Mackay, IR ;
MacSween, RNM ;
Maddrey, WC ;
Manns, MP ;
McFarlane, IG ;
zum Büschenfelde, KHM ;
Mieli-Vergani, G ;
Nakanuma, Y ;
Nishioka, M ;
Penner, E ;
Porta, G ;
Portmann, BC ;
Reed, WD ;
Rodes, J ;
Schalm, SW ;
Scheuer, PJ ;
Schrumpf, E ;
Seki, T ;
Toda, G ;
Tsuji, T ;
Tygstrup, N ;
Vergani, D ;
Zeniya, M .
JOURNAL OF HEPATOLOGY, 1999, 31 (05) :929-938
[2]   LUPUS HEPATITIS - AN UNDER-RECOGNIZED DISEASE FEATURE ASSOCIATED WITH AUTOANTIBODIES TO RIBOSOMAL-P [J].
ARNETT, FC ;
REICHLIN, M .
AMERICAN JOURNAL OF MEDICINE, 1995, 99 (05) :465-472
[3]   Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis [J].
Ballot, E ;
Homberg, JC ;
Johanet, C .
JOURNAL OF HEPATOLOGY, 2000, 33 (02) :208-215
[4]   Autoimmune hepatitis and its variant syndromes [J].
Ben-Ari, Z ;
Czaja, AJ .
GUT, 2001, 49 (04) :589-594
[5]   Extrahepatic manifestations associated with hepatitis C virus infection - A prospective multicenter study of 321 patients [J].
Cacoub, P ;
Renou, C ;
Rosenthal, E ;
Cohen, P ;
Loury, I ;
Loustaud-Ratti, V ;
Yamamoto, AM ;
Camproux, AC ;
Hausfater, P ;
Musset, L ;
Veyssier, P ;
Raguin, G ;
Piette, JC .
MEDICINE, 2000, 79 (01) :47-56
[6]  
Carpenter Herschel A, 2002, Clin Liver Dis, V6, P685, DOI 10.1016/S1089-3261(02)00022-3
[7]   Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis [J].
Czaja, AJ ;
Carpenter, HA .
HEPATOLOGY, 2004, 39 (06) :1631-1638
[8]   Nonstandard antibodies as prognostic markers in autoimmune hepatitis [J].
Czaja, AJ ;
Shums, Z ;
Norman, GL .
AUTOIMMUNITY, 2004, 37 (03) :195-201
[9]   Treatment of autoimmune hepatitis [J].
Czaja, AJ .
SEMINARS IN LIVER DISEASE, 2002, 22 (04) :365-377
[10]  
Duclos-Vallée JC, 2001, ANN MED INTERNE, V152, P371